- Home
- RCUS vs TDC Comparison
RCUS vs TDC Comparison
Compare RCUS & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- TDC
- Stock Information
- Founded
- RCUS 2015
- TDC 1979
- Country
- RCUS United States
- TDC United States
- Employees
- RCUS N/A
- TDC N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- TDC Computer Software: Prepackaged Software
- Sector
- RCUS Health Care
- TDC Technology
- Exchange
- RCUS Nasdaq
- TDC Nasdaq
- Market Cap
- RCUS 2.4B
- TDC 1.9B
- IPO Year
- RCUS 2018
- TDC 2007
- Fundamental
- Price
- RCUS $19.94
- TDC $26.20
- Analyst Decision
- RCUS Buy
- TDC Buy
- Analyst Count
- RCUS 8
- TDC 7
- Target Price
- RCUS $27.63
- TDC $29.43
- AVG Volume (30 Days)
- RCUS 1.8M
- TDC 1.8M
- Earning Date
- RCUS 10-28-2025
- TDC 11-04-2025
- Dividend Yield
- RCUS N/A
- TDC N/A
- EPS Growth
- RCUS N/A
- TDC 44.18
- EPS
- RCUS N/A
- TDC 1.21
- Revenue
- RCUS $240,000,000.00
- TDC $1,651,000,000.00
- Revenue This Year
- RCUS N/A
- TDC N/A
- Revenue Next Year
- RCUS N/A
- TDC N/A
- P/E Ratio
- RCUS N/A
- TDC $22.53
- Revenue Growth
- RCUS N/A
- TDC N/A
- 52 Week Low
- RCUS $6.50
- TDC $18.43
- 52 Week High
- RCUS $22.11
- TDC $33.20
- Technical
- Relative Strength Index (RSI)
- RCUS 64.34
- TDC 60.51
- Support Level
- RCUS $19.33
- TDC $27.13
- Resistance Level
- RCUS $20.99
- TDC $28.31
- Average True Range (ATR)
- RCUS 1.17
- TDC 0.99
- MACD
- RCUS -0.19
- TDC 0.29
- Stochastic Oscillator
- RCUS 43.93
- TDC 64.98
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About TDC Teradata Corporation
Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.